Cn /En

News Center

——

Company news

Industry news

Technical Features of the iHuPBMC-NK Platform from InnoModels Biotechnology

Author:

InnoModels

Release time:

2024-08-22

In the field of biomedical research, especially at the forefront of immunotherapy, cancer research and infectious diseases, efficient and precise experimental tools and platforms have become the key to driving scientific progress. With its innovative iHuPBMC-NK platform, InnoModels Biotechnology (Beijing) Co., Ltd. has provided researchers with a revolutionary solution that has greatly facilitated research progress in these fields.
Platform Overview
The iHuPBMC-NK platform is based on InnoModels' in-depth research on human Peripheral Blood Mononuclear Cells (PBMCs). iHuPBMC-NK is a platform that efficiently acquires and produces fully functional Natural Killer Cells (NK cells) by using advanced cell culture and expansion technologies. Natural Killer Cells (NK cells) are efficiently obtained and produced through advanced cell culture and expansion techniques. This platform not only provides researchers with high-quality and highly active NK cell products, but also ensures the reliability and reproducibility of research results through customized services and strict quality control.

Technical Features
1. Efficient production technology: The iHuPBMC-NK platform utilizes advanced cell culture and expansion technologies to efficiently obtain NK cells from human PBMCs. These NK cells are highly active and functionally intact, providing excellent tools and resources to support in vitro experiments, drug screening, and disease modeling studies.
2. Widely used fields: The platform's products are widely used in immunotherapy, cancer research, infectious diseases, etc. The efficient generation of NK cells and customized services enable researchers to respond to experimental needs more flexibly, which promotes the in-depth development of research in these fields.
3. Customized service: InnoModels Biotechnology provides customized service for customers, providing different types and quantities of NK cells according to the specific needs of research projects. This personalized service not only improves the efficiency of experiments, but also meets the urgent needs of researchers for high-quality research resources.
4. Strict quality control: The iHuPBMC-NK platform carries out strict quality control of its products to ensure that each batch of NK cells meets high quality standards. This helps to guarantee the reliability and reproducibility of the research results, providing a strong guarantee for the smooth progress of scientific research.
5. Clinical-level NK cell reconstitution: The platform achieves an extraordinary NK cell concentration of more than 100,000 cells/mL of mouse peripheral blood, and ensures that the experimental results reflect the real drug response by simulating the use of human NK cells in a clinical situation. This clinical level of NK cell reconstitution provides a more accurate and reliable experimental basis for drug efficacy assessment.
6. CD16+ cell advantage: more than 70% of the NK cells generated by the platform are CD16+ cells, and this composition ensures the physiological relevance of the platform and the accuracy of the experimental results. the advantage of CD16+ cells provides strong support for immune checkpoint studies, cytokine effect analysis, etc.
7. Seamless Integration with PDX Model: The iHuPBMC-NK platform seamlessly integrates with the Patient-Derived Xenograft Model (PDX Model) to create a comprehensive and highly predictive research environment. This combination not only improves the accuracy and reliability of the research, but also provides closer-to-clinical experimental data support for drug development and disease treatment.
Conclusion
The iHuPBMC-NK platform of InnoModels Biotechnology has set a new benchmark in the field of biomedical research with its efficient production technology, wide range of application areas, customized services, strict quality control, and clinical-level NK cell reconstruction. The platform not only provides researchers with excellent research tools and resource support, but also promotes the in-depth development of immunotherapy, cancer research and infectious diseases. In the future, with the continuous improvement and expansion of the platform technology, we have reason to believe that the iHuPBMC-NK platform will play an even more important role in the field of biomedical research, and make greater contributions to human health.

Analysis of the technical features of the iHuPBMC-B platform of InnoModels Biotechnology

Immuno-co-culture killing model platform by InnoModels Biotechnology

Analysis of the technical features of the iHuPBMC-B platform of InnoModels Biotechnology

Immuno-co-culture killing model platform by InnoModels Biotechnology

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License